Samsung has announced a breakthrough in predictive healthcare through a joint clinical study with Chung-Ang University Gwangmyeong Hospital in Korea, as reported by TechPinas . The study successfully validated the ability to predict vasovagal syncope (VVS) using biosignals collected from the Galaxy Watch6, potentially enabling smartwatches to warn users before they faint.
Researchers combined heart rate variability data from the Galaxy Watch6's PPG sensor with AI-powered analysis to predict impending fainting episodes with 84.6 percent accuracy during clinical evaluations involving patients with suspected VVS symptoms. Vasovagal syncope can cause sudden loss of consciousness, posing serious risks depending on the environment.
The study marks what Samsung describes as the world’s first successful demonstration of a commercial smartwatch being used for early syncope prediction. This reinforces Samsung's push toward personalized and preventive healthcare solutions through wearable technology, opening possibilities for safer daily living.